Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-10-050525
Filing Date
2010-09-23
Accepted
2010-09-22 18:19:32
Documents
1
Group Members
CHRISTIAN HANSENFLORIAN SCHONHARTINGNORDIC BIOTECH GENERAL PARTNER II

Document Format Files

Seq Description Document Type Size
1 v197100_sc13da.htm SC 13D/A 96164
  Complete submission text file 0001144204-10-050525.txt   98456
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51051 | Film No.: 101085342
SIC: 2834 Pharmaceutical Preparations

Mailing Address ?STERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN K G7 ----
Business Address ?STERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN K G7 ---- 45 70 20 12 63
Nordic Biotech Venture Fund II K/S (Filed by) CIK: 0001428841 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A